|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Colucid Pharmaceuticals, Inc. (CLCD) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
15,150,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$46.525 - $46.525 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
A.m. Pappas & Associates, Llc |
10% Owner |
|
2017-03-01 |
4 |
D |
$46.50 |
$92,669,571 |
I/I |
(1,992,894) |
0 |
|
- |
|
Procar Acquisition Corp |
10% Owner |
|
2017-03-01 |
4 |
A |
$46.50 |
$896,757,522 |
D/D |
19,285,108 |
100 |
|
- |
|
Skwierczynski Raymond |
Head,Pharmaceutical Operations |
|
2017-03-01 |
4 |
D |
$46.50 |
$168,098 |
D/D |
(3,615) |
0 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2017-03-01 |
4 |
D |
$46.50 |
$3,859,500 |
D/D |
(83,000) |
0 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2017-03-01 |
4 |
D |
$46.50 |
$8,068,634 |
D/D |
(173,519) |
0 |
|
- |
|
Tvm Life Science Ventures Vii L.p. |
10% Owner |
|
2017-03-01 |
4 |
D |
$46.50 |
$71,860,449 |
I/I |
(1,545,386) |
0 |
|
- |
|
Kuca Bernice |
Head,Clin. and Reg. Operations |
|
2017-03-01 |
4 |
D |
$46.50 |
$1,743,750 |
D/D |
(37,500) |
0 |
|
- |
|
Kuca Bernice |
Head,Clin. and Reg. Operations |
|
2017-03-01 |
4 |
D |
$46.50 |
$126,899 |
D/D |
(2,729) |
0 |
|
- |
|
Dallas Matthew D |
Chief Financial Officer |
|
2017-03-01 |
4 |
D |
$46.50 |
$1,743,750 |
D/D |
(37,500) |
0 |
|
- |
|
Dallas Matthew D |
Chief Financial Officer |
|
2017-03-01 |
4 |
D |
$46.50 |
$125,922 |
D/D |
(2,708) |
0 |
|
- |
|
Procar Acquisition Corp |
10% Owner |
|
2017-01-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
54,683 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2017-01-05 |
4 |
AS |
$34.25 |
$52,238 |
D/D |
(1,502) |
256,519 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2017-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
258,021 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-05 |
4 |
AS |
$33.55 |
$58,011 |
D/D |
(1,677) |
0 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-05 |
4 |
OE |
$10.00 |
$16,770 |
D/D |
1,677 |
1,677 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-04 |
4 |
AS |
$36.40 |
$6,734 |
D/D |
(185) |
0 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-04 |
4 |
OE |
$7.56 |
$1,399 |
D/D |
185 |
185 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-03 |
4 |
AS |
$36.25 |
$26,028 |
D/D |
(718) |
0 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2017-01-03 |
4 |
OE |
$6.75 |
$4,847 |
D/D |
718 |
718 |
|
- |
|
Dallas Matthew D |
Chief Financial Officer |
|
2017-01-03 |
4 |
AS |
$36.25 |
$53,396 |
D/D |
(1,473) |
40,128 |
|
- |
|
Kuca Bernice |
Head,Clin. and Reg. Operations |
|
2017-01-03 |
4 |
AS |
$36.25 |
$27,985 |
D/D |
(772) |
40,086 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2016-12-05 |
4 |
AS |
$38.75 |
$72,230 |
D/D |
(1,864) |
0 |
|
- |
|
Hogan Linda C. |
Head, Bus. Dev. and Strategy |
|
2016-12-05 |
4 |
OE |
$7.56 |
$18,186 |
D/D |
1,864 |
1,678 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2016-12-05 |
4 |
AS |
$38.75 |
$58,203 |
D/D |
(1,502) |
254,266 |
|
- |
|
Mathers Thomas P. |
Chief Executive Officer |
|
2016-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
255,768 |
|
- |
|
97 Records found
|
|
Page 1 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|